GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
35 hedge funds and large institutions have $15.6M invested in GeneDx Holdings Warrant in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
333% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 3
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
40% more funds holding
Funds holding: 25 → 35 (+10)
41% less capital invested
Capital invested by funds: $26.5M → $15.6M (-$10.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.29M |
| 2 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
+$1.1M |
| 3 |
ICM
Ionic Capital Management
New York
|
+$901K |
| 4 |
GS
Gagnon Securities
New York
|
+$720K |
| 5 |
DCP
Diameter Capital Partners
New York
|
+$529K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
-$1.38M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$537K |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$381K |
| 4 |
AC
Athanor Capital
New York
|
-$310K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$233K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
TD Asset Management
Toronto,
Ontario, Canada
| $37K | +$57.3K | +17,442 | New |
|
27
Jane Street
New York
| $27K | -$39 | -12 | -0.1% |
|
28
UBS Group
Zurich,
Switzerland
| $24K | +$23.4K | +7,127 | +174% |
|
|
AWM
29
Apollon Wealth Management
Mount Pleasant,
South Carolina
| $21K | +$32.9K | +10,000 | New |
|
30
Rockefeller Capital Management
New York
| $18K | +$28.4K | +8,629 | New |
|
|
DCM
31
Dupont Capital Management
Wilmington,
Delaware
| $14K | – | – | – |
|
32
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
33
Morgan Stanley
New York
| $1K | +$217 | +66 | +17% |
|
34
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1K | +$848 | +258 | New |
|
|
MCM
35
Moore Capital Management
New York
| – | -$1.38M | -300,000 | Closed |
|
|
DKCM
36
Davidson Kempner Capital Management
New York
| – | -$381K | -84,234 | Closed |
|
|
AA
37
AQR Arbitrage
Greenwich,
Connecticut
| – | -$233K | -50,629 | Closed |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| – | +$421 | +128 | New |
|
WGSWW Hedge Fund Activity: Q3 2021 in Review
35 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q3 2021, worth a combined $15.6M — down 41% from $26.5M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new WGSWW positions and 3 closed out — a net gain of 10 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $2.29M. The largest seller was Moore Capital Management, exiting entirely with an estimated $1.38M sold.
- 35 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q3 2021, up from 25 in Q2 2021.
- Funds reported $15.6M of GeneDx Holdings Warrant stock for Q3 2021, down 41% quarter-over-quarter.
- 13 funds opened new GeneDx Holdings Warrant positions in Q3 2021 and 3 closed out, a net change of +10 holders.
- The largest GeneDx Holdings Warrant buyer in Q3 2021 was T. Rowe Price Associates, an estimated $2.29M added.
- The largest GeneDx Holdings Warrant seller in Q3 2021 was Moore Capital Management, an estimated $1.38M sold.
Based on aggregated 13F filings for Q3 2021.